Bal Pharma Limited (BALPHARMA.NS)

INR 120.5

(-0.08%)

Annual Balance Sheets

(In INR)
Breakdown 2024 2023 2022 2021 2020 2019
Total Assets 3.2 Billion 3.13 Billion 2.6 Billion 2.4 Billion 2.38 Billion 2.61 Billion
Total Current Assets 2.35 Billion 2.28 Billion 1.84 Billion 1.64 Billion 1.61 Billion 1.81 Billion
Cash And Short Term Investments 200.49 Million 90.81 Million 60.84 Million 39.7 Million 35.06 Million 41.45 Million
Cash and Cash Equivalents 132.92 Million 14.87 Million 11.12 Million 10.23 Million 8.58 Million 24.36 Million
Short Term Investments 67.56 Million 75.93 Million 49.71 Million 29.47 Million 26.47 Million 17.09 Million
Net Receivables 1 Billion 950.81 Million 1.03 Billion 994.77 Million 899.81 Million 954.39 Million
Inventory 878.11 Million 980.05 Million 743.95 Million 603.85 Million 677.11 Million 697.51 Million
Other Current Assets 261.6 Million 259.88 Million 4.42 Million 3.13 Million -699 Thousand 125.7 Million
Total Non-Current Assets 853.78 Million 850.16 Million 759.62 Million 759.33 Million 772.57 Million 794.01 Million
Net PPE 620.77 Million 621.79 Million 572.75 Million 575.08 Million 637.69 Million 644.77 Million
Good Will And Intangible Assets 152.1 Million 142.85 Million 121.3 Million 110.76 Million 102.56 Million 95.4 Million
Good Will 38.28 Million 38.28 Million 38.28 Million 38.28 Million 38.28 Million 38.28 Million
Intangible Assets 113.81 Million 104.57 Million 83.01 Million 72.48 Million 64.28 Million 57.11 Million
Long-Term Investments 27.82 Million -40.89 Million -43.93 Million -21.41 Million 10.19 Million 7.88 Million
Tax Assets 24.12 Million 21.66 Million 18.73 Million 51.61 Million 22.11 Million -7.88 Million
Other Non Current Assets 28.97 Million 104.74 Million 90.76 Million 43.27 Million 1000.00 53.83 Million
Other Assets - 3000.00 -2000.00 - - -
Total Liabilities 2.51 Billion 2.49 Billion 2.02 Billion 1.86 Billion 1.93 Billion 2.01 Billion
Total Current Liabilities 2.03 Billion 2.09 Billion 1.65 Billion 1.52 Billion 1.59 Billion 1.63 Billion
Account Payables 783.27 Million 789.22 Million 655.63 Million 471.66 Million 386.74 Million 473.37 Million
Tax Payables 22.17 Million 23.92 Million 43.92 Million 6.13 Million 5.82 Million 4.58 Million
Short Term Debt 1.03 Billion 1 Billion 773.88 Million 863.98 Million 961.52 Million 947.45 Million
Deferred Revenue 22.17 Million 122.29 Million 192.03 Million 112.32 Million 193.77 Million 119.35 Million
Other Current Liabilities 200.94 Million 177.05 Million 34.88 Million 77.35 Million 52.87 Million 92.18 Million
Total Non Current Liabilities 472.21 Million 401.35 Million 363.95 Million 341.93 Million 335.57 Million 378.49 Million
Long-Term Debt 363.82 Million 305.23 Million 292.67 Million 255.47 Million 242.67 Million 287.56 Million
Deferred Revenue Non Current -1.00 4.51 Million 18.3 Million 19.49 Million 20.93 Million 22 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 68.78 Million 62.92 Million 46.93 Million 40.65 Million 36.13 Million 27.12 Million
Other Liabilities 1.00 - - - - -
Total Equity 692.61 Million 637.02 Million 584.92 Million 533.53 Million 453.37 Million 602.21 Million
Stock Holders Equity 692.94 Million 637.89 Million 586.26 Million 535.81 Million 524.26 Million 666.43 Million
Common Stock 158.04 Million 156.89 Million 148.22 Million 148.22 Million 141.72 Million 141.72 Million
Retained Earnings 193.41 Million 146.88 Million 135.81 Million 94.51 Million 125.86 Million 265.12 Million
Accumulated other comprehensive income 534.89 Million 32.26 Million 35.46 Million 26.3 Million 15.9 Million 18.81 Million
Common Stock Equity 692.94 Million 637.89 Million 586.26 Million 535.81 Million 524.26 Million 666.43 Million
Capital Lease Obligation 13.74 Million 20.79 Million 30.15 Million 19.23 Million 19.63 Million -
Total Investments 95.38 Million 35.04 Million 18.09 Million 23.85 Million 14.58 Million 24.98 Million
Total Debt 1.39 Billion 1.3 Billion 1.06 Billion 1.11 Billion 1.2 Billion 1.23 Billion
Net Debt 1.26 Billion 1.29 Billion 1.05 Billion 1.1 Billion 1.19 Billion 1.21 Billion

Balance Sheet Charts